For instance, miR-29b reduces the expression of sp1, a DNMT1 transactivator, and miRNA-21 decreases the activity of Ras-MAPK-DNMT1 signaling pathway in T-cells of SLE patients[65]. The gene discussed is DNMT1; the disease is systemic lupus erythematosus.